| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.23T | 1.19T | 1.15T | 1.10T | 1.05T | 1.03T |
| Gross Profit | 92.41B | 84.92B | 82.11B | 78.03B | 77.36B | 76.71B |
| EBITDA | 35.28B | 36.34B | 35.56B | 32.02B | 33.13B | 32.84B |
| Net Income | 21.90B | 22.86B | 20.64B | 19.25B | 19.64B | 19.32B |
Balance Sheet | ||||||
| Total Assets | 543.89B | 511.93B | 500.31B | 480.99B | 452.96B | 438.10B |
| Cash, Cash Equivalents and Short-Term Investments | 66.11B | 69.92B | 60.99B | 45.99B | 40.67B | 37.62B |
| Total Debt | 9.97B | 349.00M | 252.00M | 244.00M | 315.00M | 563.00M |
| Total Liabilities | 244.11B | 224.26B | 222.34B | 221.28B | 209.21B | 202.67B |
| Stockholders Equity | 299.78B | 287.67B | 277.96B | 259.70B | 243.74B | 235.43B |
Cash Flow | ||||||
| Free Cash Flow | 17.36B | 19.27B | 21.12B | 11.04B | 12.82B | 22.38B |
| Operating Cash Flow | 19.45B | 20.68B | 26.79B | 16.59B | 21.95B | 28.75B |
| Investing Cash Flow | -2.94B | -428.00M | -6.27B | -6.09B | -10.17B | -5.47B |
| Financing Cash Flow | -11.06B | -11.32B | -5.52B | -5.18B | -8.73B | -8.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥433.02B | 16.53 | 9.09% | 1.73% | 2.18% | 60.81% | |
75 Outperform | ¥284.71B | 11.95 | 7.40% | 2.30% | 3.75% | 3.77% | |
71 Outperform | ¥544.30B | 13.97 | 12.66% | 1.53% | 18.35% | 31.87% | |
70 Outperform | ¥2.72T | 24.05 | 11.50% | 2.41% | 4.62% | 47.68% | |
69 Neutral | ¥331.52B | 19.79 | 2.72% | 2.61% | 1.37% | -5.60% | |
65 Neutral | ¥415.98B | 110.37 | 5.37% | 1.95% | -3.33% | 13.76% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |